Clinical trials
Recruiting Prostatic Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 5 |
| 2023 | 9 |
| 2024 | 7 |
| 2025 | 15 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 7 |
| Amgen | 4 |
| Novartis Pharmaceuticals | 3 |
| Genentech, Inc. | 2 |
| GlaxoSmithKline | 2 |
| Merck Sharp & Dohme LLC | 2 |
| AdvanCell Pty Limited | 1 |
| Alpha-9 Oncology USA Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 53 |
| Breast Neoplasms | 11 |
| Pancreatic Neoplasms | 10 |
| Ovarian Neoplasms | 8 |
| Colorectal Neoplasms | 6 |
| Endometrial Neoplasms | 6 |
| Head and Neck Neoplasms | 6 |
| Lung Neoplasms | 6 |
| Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.